Clinical Utility and Implementation of PGT for Polygenic Disease Risk Reduction

The DEA is honored to have hosted Nathan Treff, PhD as our guest speaker where he discussed the Clinical Utility and Implementation of PGT for Polygenic Disease Risk Reduction.

Thank you everybody for attending!